VNDA compared with ASYS: revenue, margins and what each company keeps, and the suppliers and customers both name

VNDAVanda Pharmaceuticals Inc.

Mkt capRevenueRevenue

ASYSAmtech Systems Inc

Mkt capRevenueRevenue

Compare

VNDAVanda Pharmaceuticals Inc.

ASYSAmtech Systems Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

VNDA

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±11.7%▲+1.25%×0.11

Q2 FY26±18.7%▲+0.49%×0.03

Q1 FY26±13.3%▼−14.11%×1.06

Feb 12 '26±11.0%▼−17.63%×1.60

ASYS1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±18.7%▼−6.62%×0.35

= impliedVNDA realized, solidASYS realized, hatchedOne scale, both sides: full bar = 19%× = |realized| ÷ impliedSource: market data

VNDAVanda Pharmaceuticals Inc.

3.89▲+2.51%· post 3.81

Mkt cap$229.2MRevenue$70MQ3 FY26Revenue$216MFY25

ASYSAmtech Systems Inc

12.37▼−2.98%· post 12.37

ClosedNov 2 '26

Mkt cap$223.2MRevenue$22MQ3 FY26Revenue$79MFY25

Compare

ClosedNov 2 '26

VNDAVanda Pharmaceuticals Inc.

ASYSAmtech Systems Inc

3.89▲+2.51%post 3.81

Price

12.37▼−2.98%post 12.37

$229.2M

Mkt cap

$223.2M

Q3 FY26$70M

Revenue

$22MQ3 FY26

FY25$216M

Revenue

$79MFY25

VNDA3.89▲+2.51%vsASYS12.37▼−2.98%ClosedNov 2 '26